LivingGLP1
Study S002318

Evaluation of the Glycemic Impact of Food in Patients With Type 2 Diabetes Taking Glargine and/or Exenatide

ClinicalTrials.gov record

Registration

Registration
NCT01237314
Acronym
REACT2
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
46
Start
2010-11
Primary completion
2013-05
Lead sponsor
HealthPartners Institute
Conditions
Type 2 Diabetes
Results posted
FALSE

Registered primary outcomes

  • 4-hour glycemic response at 3 time points [4 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.